Shareholding disclosure

Santhera Pharmaceuticals Holding AG

Declared position

52.54%

Threshold

Crossed downwards

Timeline

Published

07.04.2021

Transaction

29.03.2021

Voting rights breakdown

Voting rights acquired9.78%
Voting rights sold52.54%
Below threshold0%

Notice details

CategorySingle shareholder
ExchangeXSWX

Notification ID

TAL4600023

Beneficial owner

Santhera Pharmaceuticals Holding AG

Declared address

Santhera Pharmaceuticals Holding AG, Pratteln

Acquisition and disposal of shares on March 29, 2021; also regarding certain sales positions.

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open